The startup is working to develop pharmaceutical technology born out of Johns Hopkins University. Source: BioSpace

BridgeBio stepped in to take over the drug and also launch a subsidiary, QED Therapeutics, to drive the development of infigratinib. Source: BioSpace

A look at three intriguing biotech stocks that are seeing big insider buying from top-ranked insiders right now. Source: BioSpace

Rare disease giant Shire plunked down an undisclosed sum to get its hands on a preclinical autoimmune drug candidate being developed by AB Biosciences. Source: BioSpace

Since 2013, Dr. Perlmutter has served as executive vice president of Merck and president of Merck Research Laboratories. Source: BioSpace

The FDA will establish a council to oversee all animal studies under the agency’s purview. Source: BioSpace

A look at three small biotechs that big drugmakers are drooling over. Source: BioSpace

The FDA's Breakthrough Therapy Designation for balovaptan was primarily based on efficacy findings in the VANILLA study, a Phase II trial of balovaptan in adults with ASD. Source: BioSpace

AbbVie provided an unexpectedly strong 2018 guidance revision, largely built on the new corporate tax rate. Source: BioSpace

the FDA has determined that it cannot approve the NDA in its present form and provides specific reasons for this action along with recommendations needed for resubmission. Source: BioSpace